NHI — National Health Investors Income Statement
0.000.00%
Last trade - 00:00
- $3.90bn
- $5.04bn
- $319.84m
- 70
- 40
- 98
- 78
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 318 | 333 | 299 | 278 | 320 |
Cost of Revenue | |||||
Gross Profit | 312 | 323 | 287 | 240 | 269 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 158 | 144 | 218 | 242 | 201 |
Operating Profit | 160 | 188 | 80.7 | 36.6 | 119 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 160 | 185 | 112 | 65.5 | 134 |
Net Income After Taxes | 160 | 185 | 112 | 65.5 | 134 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 160 | 185 | 112 | 66.4 | 136 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 160 | 185 | 112 | 66.4 | 136 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.75 | 3.77 | 2.93 | 2.23 | 2.82 |
Dividends per Share |